Table 4 Clinical outcomes at 30-day.
From: Manual compression versus MANTA device for access management after impella removal on the ICU
Overall (n = 87) | MANTA device (n = 31) | Manual compression (n = 56) | P-value† | ||
|---|---|---|---|---|---|
Any packed RBC transfusion | 2 (0–5) | 0 (0–4) | 3 (1–5) | 0.004 | |
ICU stay (days) | 5 (3–10) | 4 (3–8) | 6 (4–11) | 0.14 | |
Duration of hospital stay (days) | 11 (7–20) | 10.5 (7–18) | 11 (7–20.5) | 0.91 | |
Clinical outcomes at 30-days | HR (95%CI) | ||||
Minor bleeding (BARC 2)* | 14 (16.1) | 6 (19.4) | 8 (14.3) | 0.81 (0.23–2.86) | 0.74 |
Major bleeding (BARC 3/5)* | 37 (42.5) | 13 (41.9) | 24 (42.9) | 0.87 (0.38–2.02) | 0.75 |
New MI | 5 (5.7) | 4 (12.9) | 1 (1.8) | 0.13 (0.01–1.18) | 0.07 |
Stroke/TIA | 6 (6.9) | 2 (6.5) | 4 (7.1) | 1.08 (0.2–5.91) | 0.92 |
New heart failure | 11 (12.6) | 7 (22.6) | 4 (7.1) | 0.26 (0.06–1.03) | 0.054 |
Repeat CS | 7 (8.0) | 3 (9.7) | 4 (7.1) | 0.71 (0.16–3.19) | 0.65 |
Sepsis | 9 (10.3) | 4 (12.9) | 5 (8.9) | 0.68 (0.18–2.52) | 0.56 |
Cardiovascular death | 18 (20.7) | 7 (22.6) | 11 (19.6) | 0.87 (0.34–2.26) | 0.78 |
All-cause death | 18 (20.7) | 7 (22.6) | 11 (19.6) | 0.87 (0.34–2.26) | 0.78 |
